Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. (DAWN) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
DAWN · net income · updated Jun 9, 2026
Core profitability metrics
DAWN · net income · margin · TTM · CAGRNet income was −$107.3M for FY2025 (fiscal year ending 2025-12-31), down 12.4% year-over-year. Net profit margin was -67.8%.
Annual net income history
▸ FMP /income-statement · Annual · DAWN net income history · DAWN profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Day One Biopharmaceuticals, Inc. (DAWN) reported net income of −$107.3M for FY2025 (fiscal year ending 2025-12-31), down 12.4% year-over-year. The net profit margin was -67.8% — meaning the company kept $-0.68 of every dollar of revenue as profit.
Day One Biopharmaceuticals, Inc. has not yet achieved annual profitability based on available data (7 fiscal years). The company has reported net losses across all available periods.
Day One Biopharmaceuticals, Inc.'s net profit margin was -67.8% for FY2025, based on the latest annual results.
Investors sometimes search for "Day One Biopharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from DAWN net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
DAWN net income · 4 questionsDay One Biopharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $107.3M for FY2025.
▸ Source: FMP /income-statement · GAAP · Day One Biopharmaceuticals, Inc. · Day One Biopharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026